PortViewPortView
Hill-Rom logo

Hill-Rom (HRC) Stock Analysis

NYSEHealthcareMedical - Instruments & Supplies

$155.96+0.03%
1-year price historyRange $149.29 – $156.18
52-week range$155.96
$93.34$156.22

What Hill-Rom does

Hill-Rom Holdings, Inc. functions as a global enterprise specializing in medical technology, structured into three primary operational areas: Patient Support Systems, Front Line Care, and Surgical Solutions. The Patient Support Systems division provides a variety of essential equipment, including medical-surgical, intensive care unit, and bariatric patient beds, alongside patient lifts and related devices, non-invasive therapeutic surfaces, and cutting-edge information technology and software. This segment also offers service contracts for its capital equipment. Under its Front Line Care offerings, the company furnishes comprehensive patient monitoring and diagnostic instruments. These encompass general patient examination and diagnostic tools, continuous patient monitoring systems, diagnostic cardiology products, and vision screening devices. Additionally, it supplies a suite of respiratory health products, such as the Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000, all designed to facilitate the mobilization of retained blockages in patients. The Surgical Solutions segment delivers critical operating room infrastructure, including surgical tables, specialized lighting, and ceiling-mounted pendants. It also manufactures precision positioning devices for various procedures like shoulder, hip, spinal, and lithotomy surgeries, along with universal positioning accessories compatible with diverse operating room tables. Hill-Rom's products and services reach a broad spectrum of healthcare providers. They are distributed and leased directly to acute and extended care facilities through its dedicated sales force and various distributors. The company also sells and rents directly to individual patients for home use and supplies primary care facilities via distribution partners. Its comprehensive clinical offerings cater to acute care, primary care, and even clinical research organizations. Established in 1969, Hill-Rom Holdings, Inc. maintains its headquarters in Chicago, Illinois.

Key metrics

Market cap
$0
P/E (TTM)
41.92
EPS (TTM)
$3.72
Beta
0.55
Dividend yield
0.60%
Revenue / share
$45.16
50-day avg
$154.34
200-day avg
$130.22
52-week high
$156.22
52-week low
$93.34
CEO
John Groetelaars

ETFs linked to HRC

Broad-market and Healthcare sector ETFs an investor holding Hill-Rom is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how HRC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze HRC in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Hill-Rom?
Hill-Rom trades under the ticker HRC on NYSE.
Which exchange is HRC listed on?
HRC is listed on NYSE.
What sector does Hill-Rom operate in?
Hill-Rom is classified in the Healthcare sector (Medical - Instruments & Supplies industry).
How can PortView help analyze HRC in a portfolio?
PortView shows HRC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.